These results imply that ATG4B inhibition might be able to block proliferation and sensitize oral cancer cells to chemotherapeutic drugs or radiation therapy, but this hypothesis would need to be evaluated with further study. This evidence concerns the gene ATG4B and lip and oral cavity carcinoma.